The heterogeneity of study populations and variability in ALL classification criteria—such as the ALL IC BFM, FAB classification, and NCI criteria—introduce variability in VEGF‐A levels reported across studies. The gene discussed is VEGFA; the disease is acute lymphoblastic leukemia.